Scientists find 160 new drugs that may fight against COVID-19
In a new study from the University of Cambridge, researchers have identified 200 approved drugs predicted to work against COVID-19—of which only 40 are...
COVID-19—smell, taste and recovery of flavor
2020 was a doozy of a year, to say the least! As 2021 continues to transition us out of the COVID-19 pandemic thanks to...
COVID-19 variants explained
As the so-called Delta variant of SARS-CoV-2, the virus that causes COVID-19, threatens to spread in more places in the U.S., some may wonder...
Pfizer and Moderna vaccines may protect against COVID-19 for years
In a new study from Washington University in St. Louis, researchers found the Pfizer and Moderna vaccines trigger an immune system response that could...
Fatigue, cognitive impairment and mood disorders linked to post-COVID-19 syndrome
In a new study from Mayo Clinic, researchers found people diagnosed with the post-COVID-19 syndrome, also known as "COVID-19 long-haul syndrome”, experience symptoms such...
Staying fit may decrease death risk in COVID-19
In a new study from the University of Toronto, researchers found that improving your heart and respiratory fitness level may help protect you from...
MRNA vaccines can help fight cancer, study finds
Thanks to researchers in different fields who put in nearly two decades of past work on mRNA vaccine technology, people around the world are...
Autopsy study shows how COVID-19 damages the brain
In a new study from Stanford University, researchers found the brains of people who died from COVID-19 were remarkably similar to the brains of...
Scientists find the cause of long COVID-19 symptoms
In a new study from World Organization and elsewhere, researchers found that Epstein-Barr virus (EBV) reactivation resulting from the inflammatory response to coronavirus infection...
Here’s what you should know about the Delta variant
When it comes to infectious diseases, the United Kingdom is like the "canary in our mine," according to Texas A&M University virologist Benjamin Neuman.
When...









